Big Pharma Disappoints on Revenues, Earnings

While Big Pharma stocks have been a standout within health care this year, earnings have disappointed, leading analysts to call it a trend. Pharmaceutical companies have seen drops of 4.7 percent in earnings and 3.2 percent in revenues.